Beta-amyloid peptide-induced blood-brain barrier disruption facilitates T-cell entry into the rat brain.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Acta Histochemica

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1078/0065-1281-00696PMID 12831163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions

  2004cited by this paper
• Cyclooxygenase‐2‐positive macrophages infiltrate the Alzheimer’s disease brain and damage the blood–brain barrier

  2002cited by this paper
• Flow Cytometric Analysis of Inflammatory Cells in Ischemic Rat Brain

  2002cited by this paper
• Effect of endothelial cell polarity on beta-amyloid-induced migration of monocytes across normal and AD endothelium.

  2002cited by this paper
• Cellular mechanisms by which tumor necrosis factor-alpha produces disruption of the blood-brain barrier.

  2002cited by this paper
• Tumour necrosis factor-α causes an increase in blood-brain barrier permeability during sepsis

  2001cited by this paper
• A Vascular Connection to Alzheimer's Disease

  2001cited by this paper
• Rapid entry and downregulation of T cells in the central nervous system during the reinduction of experimental autoimmune encephalomyelitis.

  2001cited by this paper
• Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis.

  2001cited by this paper
• Heritability of plasma amyloid β in typical late‐onset Alzheimer’s disease pedigrees

  2001cited by this paper
• Cell mediators of inflammation in the Alzheimer disease brain.

  2000cited by this paper
• Focal inflammation in the brain

  2000cited by this paper
• Plasma β‐Amyloid Peptide, Transforming Growth Factor‐β1, and Risk for Cerebral Amyloid Angiopathy

  2000cited by this paper
• Plasma beta-amyloid peptide, transforming growth factor-beta 1, and risk for cerebral amyloid angiopathy.

  2000cited by this paper
• Brain‐immune connection: Immuno‐regulatory properties of CNS‐resident cells

  2000cited by this paper
• beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1.

  2000cited by this paper
• In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1.

  1999cited by this paper
• Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice.

  1999cited by this paper
• Chemokine and Inflammatory Cell Response to Hypoxia-Ischemia in Immature Rats

  1999cited by this paper
• Immune regulation and CNS autoimmune disease.

  1999cited by this paper
• Intravascular infusions of soluble β-amyloid compromise the blood–brain barrier, activate CNS glial cells and induce peripheral hemorrhage

  1999cited by this paper
• Amyloid-beta peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1.

  1999cited by this paper
• Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure.

  1999cited by this paper
• Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway.

  1999cited by this paper
• Activated non-neural specific T cells open the blood-brain barrier to circulating antibodies.

  1999cited by this paper
• Leukocyte traffic in the central nervous system: the participants and their roles.

  1999cited by this paper
• Neuronal Control of the Immune Response in the Central Nervous System: Linking Brain Immunity to Neurodegeneration

  1998cited by this paper
• Antigen-independent activation of resting T-cells in the liver of patients with chronic hepatitis.

  1998cited by this paper
• Immune cell entry to the CNS--a focus for immunoregulation of EAE.

  1998cited by this paper
• Beta-amyloid (1-42) peptide impairs blood-brain barrier function after intracarotid infusion in rats.

  1998cited by this paper
• Amyloid-β Induces Chemokine Secretion and Monocyte Migration across a Human Blood-Brain Barrier Model

  1998cited by this paper
• Immune Surveillance in the Injured Nervous System: T-Lymphocytes Invade the Axotomized Mouse Facial Motor Nucleus and Aggregate around Sites of Neuronal Degeneration

  1998cited by this paper
• β-AMYLOID FRAGMENT POTENTIATES IL-6 AND TNF-α SECRETION BY LPS IN ASTROCYTES BUT NOT IN MICROGLIA

  1997cited by this paper
• Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor‐α in the central nervous system

  1997cited by this paper
• Beta-amyloid fragment potentiates IL-6 and TNF-alpha secretion by LPS in astrocytes but not in microglia.

  1997cited by this paper
• Microglial in neurodegenerative disorders: emphasis on Alzheimer's disease.

  1997cited by this paper
• Effect of tumor necrosis factor-alpha on the permeability of bovine brain microvessel endothelial cell monolayers.

  1997cited by this paper
• Spinal cord compression injury in guinea pigs: structural changes of endothelium and its perivascular cell associations after blood-brain barrier breakdown and repair.

  1997cited by this paper
• APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease.

  1996cited by this paper
• Intracarotid tumor necrosis factor-α administration increases the blood-brain barrier permeability in cerebral cortex of the newborn pig: Quantitative aspects of double-labelling studies and confocal laser scanning analysis

  1996cited by this paper
• Cytokines in inflammatory brain lesions: helpful and harmful.

  1996cited by this paper
• Lymphocyte Targeting of the Central Nervous System: A Review of Afferent and Efferent CNS‐Immune Pathways

  1996cited by this paper
• Activation of microglial cells by beta-amyloid protein and interferon-gamma.

  1995cited by this paper
• Activation of microglial cells by β-amyloid protein and interferon-γ

  1995cited by this paper
• TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.

  1995cited by this paper
• Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.

  1995cited by this paper
• Lymphocytic Infiltration and Expression of Intercellular Adhesion Molecule-1 in Photochemically Induced Ischemia of the Rat Cortex

  1995cited by this paper
• Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion.

  1994cited by this paper
• Inflammatory cytokines in the brain: does the CNS shape immune responses?

  1994cited by this paper
• An antiserum reacts with an evolutionary conserved region in the epsilon subunit of the T-cell receptor-CD3 complex in phylogenetically distant species.

  1993cited by this paper
• Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells.

  1993cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• Microglial cells are a component of the perivascular glia limitans

  1991cited by this paper
• Mechanisms of inflammatory cell attachment in chronic relapsing experimental allergic encephalomyelitis: a scanning and high-voltage electron microscopic study of the injured mouse blood-brain barrier.

  1991cited by this paper
• Migration of Hematogenous Cells Through the Blood‐Brain Barrier and the Initiation of CNS Inflammation

  1991cited by this paper
• Expression of Adhesion Molecules and Histocompatibility Antigens at the Blood‐Brain Barrier

  1991cited by this paper
• T‐lymphocyte entry into the central nervous system

  1991cited by this paper
• Vasogenic brain edema in focal 4-aminopyridine seizures: the role of neuronal hyperactivity.

  1990cited by this paper
• Macrophages and microglia in the nervous system.

  1988cited by this paper
• Blood‐brain barrier studies with special reference to epileptic seizures

  1988cited by this paper
• The nature of inflammatory components during demyelination in multiple sclerosis.

  1988cited by this paper
• Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo.

  1988cited by this paper
• Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system.

  1987cited by this paper
• Microglia are the major cell type expressing MHC class II in human white matter.

  1987cited by this paper
• Cellular immune reactivity within the CNS

  1986cited by this paper
• The fate of allogeneic and xenogeneic neuronal tissue transplanted into the third ventricle of rodents.

  1986cited by this paper
• Characterization of inflammatory infiltrates in experimental allergic encephalomyelitis

  1986cited by this paper
• Acute experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion.

  1985cited by this paper
• Expression of Ia molecules by astrocytes during acute experimental allergic encephalomyelitis in the Lewis rat.

  1985cited by this paper
• Immunohistochemical staining of human brain with monoclonal antibodies that identify lymphocytes, monocytes, and the Ia antigen.

  1983cited by this paper
• The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

  1981cited by this paper
• Neuroimmunologic Diseases: Effector Cell Responses and Immunoregulatory Mechanisms

  1981cited by this paper
• Distribution and quantitation of HLA-ABC and DR (Ia) antigens on human kidney and other tissues.

  1980cited by this paper
• Immunologically privileged sites.

  1977cited by this paper

• In Vitro Assessment of the Neuroprotective Effects of Pomegranate (Punica granatum L.) Polyphenols Against Tau Phosphorylation, Neuroinflammation, and Oxidative Stress

  2024cites this paper
• The Immunopathy of Alzheimer's Disease: Innate or Adaptive?

  2023cites this paper
• Post-Ischemic Permeability of the Blood–Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer’s Disease-Type Brain Neurodegeneration

  2023cites this paper
• A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model

  2022cites this paper
• Coffee: Health effects and various disease treatments

  2022cites this paper
• Interleukin-17 Promotes the Infiltration of CD8+ T Cells into the Brain in a Mouse Model for Alzheimer’s Disease

  2022cites this paper
• Diagnosing Alzheimer’s Disease from Circulating Blood Leukocytes Using a Fluorescent Amyloid Probe

  2021cites this paper
• Hippocampal Sclerosis in Pilocarpine Epilepsy: Survival of Peptide-Containing Neurons and Learning and Memory Disturbances in the Adult NMRI Strain Mouse

  2021cites this paper
• Caffeine effects on systemic metabolism, oxidative-inflammatory pathways, and exercise performance.

  2020cites this paper
• Exploring Potential of Alkaloidal Phytochemicals Targeting Neuroinflammatory Signaling of Alzheimer's Disease.

  2020cites this paper
• Progress in Microbes and Molecular Biology

  2020cites this paper
• Selenium and Cognition: Mechanism and Evidence

  2019cites this paper
• Th17 and Cognitive Impairment: Possible Mechanisms of Action

  2019cites this paper
• The role of neutrophil granule proteins in neuroinflammation and Alzheimer’s disease

  2018cites this paper
• Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics.

  2018cites this paper
• From Single Acute Seizure to Chronic Epilepsy in Experimental Animals : The Role of Glutamate Receptors and Brain Damage

  2018cites this paper
• A novel dynamic multicellular co-culture system for studying individual blood-brain barrier cell types in brain diseases and cytotoxicity testing

  2018cites this paper
• Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases

  2017cites this paper
• APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease

  2016cites this paper
• Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles.

  2015cites this paper
• A New Role for Beta-Amyloid in Alzheimer's Disease: Initiation of Thrombotic and Inflammatory Processes Via Coagulation Factor XII and Fibrinogen

  2015cites this paper
• Drug Access to the Central Nervous System in Alzheimer’s Disease: Preclinical and Clinical Insights

  2014cites this paper
• Pathology Associated with AAV Mediated Expression of Beta Amyloid or C100 in Adult Mouse Hippocampus and Cerebellum

  2013cites this paper
• Th17 Cell-Mediated Neuroinflammation Is Involved in Neurodegeneration of Aβ1-42-Induced Alzheimer’s Disease Model Rats

  2013cites this paper
• Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier.

  2013cites this paper
• Alzheimer's Factors in Ischemic Brain Injury

  2012influential citation
• Challenging the Role of Adaptive Immunity in Neurotrauma: Rag1−/− Mice Lacking Mature B and T Cells Do Not Show Neuroprotection after Closed Head Injury

  2012cites this paper
• The effect of plant derived and endogenous substances on the spinal mechanisms of pain in rats

  2011cites this paper
• Transport of drugs across the blood-brain barrier in Alzheimer's disease.

  2010cites this paper
• Caffeine Protects Against Disruptions of the Blood-Brain Barrier in Animal Models of Alzheimer's and Parkinson's Diseases

  2010cites this paper
• ULTRASTRUCTURAL MALFORMATIONS OF THE CEREBRAL MICROVESSELS IN PATHOLOGICAL CONDITIONS AN ELECTRON MICROSCOPIC STUDY

  2010cites this paper
• Preliminary Evaluations of the Effects of Quinazolinones on Internal Organs of " ewborn Balb / C Mice

  2010cites this paper
• Why Alzheimer's Disease Starts with a Memory Impairment: Neurophysiological Insight

  2010cites this paper
• Consideration of the ischaemic basis and treatment of Alzheimer's disease.

  2010influential citation
• Factors in creepy delayed neuronal death in hippocampus following brain ischemia-reperfusion injury with long-term survival.

  2010cites this paper
• Vascular Endothelial Barrier Dysfunction Mediated by Amyloid-β Proteins

  2009cites this paper
• Amyloid Precursor Protein Mediates a Tyrosine Kinase-Dependent Activation Response in Endothelial Cells

  2009cites this paper
• Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration.

  2009cites this paper
• Human Truncated Tau is Using a Different Mechanism from Amyloid-β to Damage the Blood-Brain Barrier

  2009cites this paper
• Central regulation of Blood Brain Barrier integrity during hyperalgesia

  2009cites this paper
• Ionotropic glutamate antagonism in the 4-aminopyridine rat convulsion model: the morphological and functional aspects of the acute seizure

  2009cites this paper
• Brain ischemia and ischemic blood–brain barrier as etiological factors in sporadic Alzheimer’s disease

  2008cites this paper
• Soluble aggregates of the amyloid‐β protein selectively stimulate permeability in human brain microvascular endothelial monolayers

  2008cites this paper
• Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.

  2008cites this paper
• Role of ischemic blood-brain barrier on amyloid plaques development in Alzheimer's disease brain.

  2007cites this paper
• Comparative Effects of Aβ(1-42)-Al Complex from Rat and Human Amyloid on Rat Endothelial Cell Cultures

  2007cites this paper
• Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain.

  2006cites this paper
• Alzheimer’s disease, brain immune privilege and memory: a hypothesis

  2006cites this paper
• Tumor necrosis factor-alpha increases cerebral blood flow and ultrastructural capillary damage through the release of nitric oxide in the rat brain.

  2006cites this paper
• Is the ischemic blood–brain barrier insufficiency responsible for full-blown Alzheimer's disease?

  2006cites this paper
• Structural and functional MRI following 4-aminopyridine-induced seizures: a comparative imaging and anatomical study.

  2006cites this paper
• Effects of adoptive transfer of beta-amyloid sensitive immune cells in a mouse model for Alzheimer's disease

  2005cites this paper
• 6‐Hydroxydopamine‐induced alterations in blood–brain barrier permeability

  2005cites this paper
• Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFα or both

  2005cites this paper
• Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both.

  2005cites this paper
• Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain

  2004cites this paper
• University of Groningen Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain Farkas,

  2004cites this paper
• APP Regulates Microglial Phenotype in a Mouse Model of APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease Alzheimer's Disease

  year unknowncites this paper
• Frontiers in Aging Neuroscience Aging Neuroscience

  year unknowncites this paper